Author

J. Berrigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

E. Muhlberger· 2 shared J. Olejnik· 2 shared S. Gummuluru· 2 shared A. L. Tse· 1 shared A. M. Chandran· 1 shared A. Nisa· 1 shared C. Costello· 1 shared C. Lemeunier· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Muhlberger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Distinct pathway for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses

A. L. Tse, C. M. Acreman, I. Ricardo-Lax, J. Berrigan, G. Lasso, T. Balogun, F. L. Kearns, L. Casalino, G. L. McClain, A. M. Chandran, C. Lemeunier, R. E. Amaro, C. M. Rice, R. K. Jangra, J. S. McLellan, , E. H. Miller

The paper investigates how SARS-like bat coronaviruses evolve enhanced receptor binding and cell entry through specific genetic substitutions.

bioRxiv · Jun 24, 2024Microbiology

CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses

S. Jalloh, J. Olejnik, J. Berrigan, A. Nisa, E. L. Suder, H. Akiyama, M. Lei, S. Tyagi, Y. Bushkin, E. Muhlberger, S. Gummuluru

This study shows CD169 enables ACE2-independent SARS-CoV-2 entry in macrophages, leading to restricted viral replication and pro-inflammatory cytokine production.

bioRxiv · Mar 29, 2022Immunology

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2

R. Amraei, M. Napoleon, W. Yin, J. Berrigan, E. Suder, G. Zhao, J. Olejnik, K. Chandler, C. Xia, S. Gummuluru, E. Muhlberger, V. Chitalia, C. Costello, N. Rahimi

This study identifies CD209L/L-SIGN and CD209/DC-SIGN as alternative receptors for SARS-CoV-2, capable of mediating virus entry into human cells, particularly in tissues with low ACE2 expression.

bioRxiv · Jun 22, 2020 · PreprintCell Biology